| Logo | Name | Σ | Employees |
|---|---|---|---|
 |  TRIANNI, Inc an AbCellera Company Exceptional Human Antibody Discovery Technology Trianni, Inc. is a biotech company specializing in human antibody discovery platform technology. We offer the leading in vivo platform enabling efficient discovery of fully-human monoclonal antibodies. The Trianni Mouse offers biologic drug discoverers a best-in-class solution for the isolation of therapeutic antibody candidates. Benefits over older conventional mouse immunization + humanization approaches include superior lead panels with respect to potency and diversity along with speed to the clinic and lower operating costs. We aim to make Trianni’s premium technology available to any Pharma or Biotech company engaged in antibody discovery by offering flexible licenses … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 0 | 1 |
 |  Generis Tomorrow's Connection Today GENERIS IS A FULL-SERVICE ORGANIZER OF WORLD CLASS BUSINESS SUMMITS We provide leading industry insight, innovative onsite technical and strategic expertise through a platform uniquely designed for executives and professionals to connect. Our experience spans across two decades in successfully developing and delivering high-quality business to business events and services across various industries. Generis was formed with the vision of redefining the way in which knowledge transfer and face to face interactions take place. We see an opportunity to enhance the partnership experience through our understanding of how executives and professionals create and sustain successful relationships. Our … Type: Startup Activities: healthtech spacetech deeptech biotech transporttech Technologies: Synthetic Biology | 94 | 109 |
 | Immune Biosolutions inc. Actor of change Immune Biosolutions is a clinical-stage biotechnology company specializing in the discovery and engineering of avian and human antibodies for therapeutic applications. Utilizing cutting-edge technologies, we develop custom immunotherapeutic agents. Our discovery platform efficiently targets complex proteins and generate powerful, specific, and innovative antibodies. Additionally, our antibody production capability allows us to advance our own discovery programs in cancer and autoimmune diseases into the early phases of clinical development. Anticorps, Custom antibody development, Antibody, Développement sur mesure de génération d'anticorps, IgY, Chicken, Poulet, ELISA, Therapeutic Antibodies, Recombinant Antibodies, Humanized Antibodies, GPCRs, and Oncology Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 6 | 24 |
 | Sedna Technologies Unleashing the power of data and technology within the seafood sector Sedna Technologies is a fisheries technology firm based out of Nova Scotia, Canada. The focus of Sedna is to increase the traceability of seafood products by creating innovative and simple to use software solutions for exporters, processors, distributors and harvesters involved in international and domestic trade. Our systems are built from the ground up, ensuring they are easy to implement and maintain. We design our systems to your specifications; our technology can allow for your clients to understand the origin and journey of your products. Allowing for greater marketability … Type: Startup Activities: biotech deeptech it services Technologies: A.I. IoT Sensors Wireless | 0 | 5 |
 | DNAstack DNAstack's mission is to save and improve lives through AI-powered discoveries across global networks of genomics and he DNAstack creates cutting edge software technologies that help scientists more easily discover, access, and analyze the world’s exponentially growing volumes of genomic and clinical data. genomics, bioinformatics, cloud, and big data Type: Startup Activities: deeptech it services biotech Technologies: Data Analytics | 8 | 31 |
 | Astral Solutions Group | Your Finance Digital Transformation Partner Finance Digital Transformation Advisory, Consulting | Corporate Performance Management At Astral Solutions Group, we provide Finance transformation advisory and consulting includes Consolidation, Planning, Budgeting and Forecasting, Financial Reporting, Sales Profitability, and Costing. CPM/EPM Development, implementation and Support services to the Office of Finance. Industries We Serve: Manufacturing, Construction, REIT, Pharmaceuticals, Banks, Mining, Higher Education, We are experienced in addressing the requirements of an organization from project inception through the successful delivery and adoption of the completed solution. Software Expertise: #OneStreamSoftware #OracleEPM #Hyperion #Prophix #Planful #Microsoft PowerBI Oracle EPM On-Cloud Enterprise Planning and Budgeting Cloud (EPBCS) Planning and … Type: Startup Activities: it services biotech deeptech Technologies: Data Analytics | 2 | 19 |
 | Evolving Therapeutics Evolution. Adaptation. Future. Phage-based solutions to combat bacteria. - Prevention - Diagnosis - Treatment "One Health" personalized treatments. biotecnología, microbiología, investigación, biomedicina, bacteria, phage, and phage therapy Type: Startup Activities: biotech deeptech healthtech Technologies: Synthetic Biology | 0 | 4 |
 | Iodysséus Awareness program for the marine environment, plankton. Ocean Data & amp; Models. The Iodysséus program is carried by the Endowment Fund Science & Amp; SEA. They are invisible to the naked eye but regulate our climate and participate in making our planet breathable. They impact our daily life, our health, our savings ... "they" are myriads of particles and microorganisms in suspension in aerosols above the ocean. Their interactions, between atmosphere and surface, in the global climatic machinery is not unknown. But we cannot configure them. The losses induced by disturbances of which they are vectors amount to a hundred … Type: NGO, Think-tanks, Ed, & Culture Activities: cleantech biotech deeptech greentech | 6 | 3 |
 | Alternative Plants Cellular farmers using biotechnology to unlock the full potential of botanical resources. A biotech company dedicated to production of cosmetic ingredients from plant stem cells. We focus on cell cultures of endangered Nordic plants thus using plant biotechnology to make inaccessible treasures accessible. The value we provide is not only a new ingredient - our routine is scrupulous chemical characterisation and efficacy testing to deliver excellent ingredients along with a set of ready-to-use efficacy claims. Cosmetic ingredients, Plant derived active ingredients, In vitro efficacy testing, Anti-ageing ingredients, Skin whitening ingredients, Antioxidants, Plant cell culture, Organic ingredients, and Efficacy claiming Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 4 | 9 |
 |  ProXentia Bioanalysis in a new light ProXentia produces innovative analysis systems for safety and quality monitoring in the food supply chain. ProXentia’s device allows rapid analysis of raw materials entering and leaving the company. Because of its simplicity, the tests can be performed directly in the production or storage site, for more effective control and greater safety. The technology of ProXentia exploits light as a probing tool. The PRX device is indeed based on the proprietary RPI (Reflective Phantom Interface) technology, which exploits the light reflection of innovative materials and allows to perform rapid multiparametric diagnostic tests in a simple way … Tags: H2020 Type: Startup Activities: deeptech biotech healthtech Technologies: New Materials Sensors | 1 | 1 |
 | Moon Rabbit Through Crypto We Seek Immortality Moon Rabbit is a vertically integrated crypto-meritocratic techno-conglomerate — 安居財閥 (AngoZaibatsu) — constituting a system of systems (Jurisdictions) with the overarching mission of seeking to discover the secret to eternal life — whether biologically or digitally — and to enable humanity to transcend the known dimensions and experience new worlds and spiritual states. blockchain, cryptocurrencies, Ethereum, bitcoin, crypto, dlt, biotech, longevity, polkadot, and web3 Type: NGO, Think-tanks, Ed, & Culture Activities: it services biotech deeptech healthtech foodtech | 17 | 4 |
 | GenNext Turf GenNext M3DTM Exoenzymes allow your plants to take on the attributes of the world's most resilient natural grasses Harvested from nature's richest soils, GenNext M3DTM Technology allows your plants to take on the attributes of the world's most resilient natural grasses. We identify and extract over 3,000 specific proteins, hormones, and enzymes – the good stuff – from select microbes found in natural prairie grasses, corn composts, and various turfgrass species. Each of these microbes has a specific function, whether to decompose dead matter to form organic material, to free “tied-up” nutrients from the soil and from dead matter, or … Type: Startup Activities: agritech biotech deeptech Technologies: Bio sourced materials | 0 | 2 |
 | Pharmtec BIOKILL - Decontamination stations We are the only company on the market specializing in high purity applications at the same time as biosecurity applications. We are based on our know-how on more than 50 years of experience in sterilization in aseptic production, and apply the same strict requirements in terms of biological decontamination of effluents. Pharmtec's patented technology guarantees high resistance to clogging, while offering higher and validable performance. Aseptic production, lyophilizer, EPPI system, pure steam generator, BPF and CGMP autoclave, sterilization and depyrogenization ovens, insulators, DSVA - H202 decontamination systems, Tofflon, and pneumatic transfer of powders Type: SMB Activities: biotech deeptech industry 4.0 | 0 | 11 |
 | Rheos Medicines Rheos Medicines is a biopharmaceutical company harnessing insights in immunometabolism to develop a novel class of medicines with potential to transform the lives of patients with immune mediated diseases. We are rapidly applying a first-in-field approach in immunometabolism with a comprehensive, systems-biology understanding of the metabolic pathways that drive immune cell function and fate coupled to a biomarker discovery effort with potential to bring precision to the treatment of immune-mediated diseases. Launched in 2018 by Third Rock Ventures with a $60 million Series A financing, Rheos is built on groundbreaking science from pioneers in the field, our passionate team of … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 1 | 23 |
 | Ambiotis Your partner to resolve inflammation Ambiotis is a pre-clinical CRO specialized in the study of inflammatory processes and the active end of inflammation, called resolution. Resolution is now recognized as the necessary biological process to stop inflammation and restore homeostasis in tissues. This recent approach makes possible to study the inflammation process in a completely innovative and differentiating way. Ambiotis proposes services adapted to pharmaceutical, dermo-cosmetic, agro- food/nutraceutical industries to evaluate the potential of their molecules at preclinical or clinical stages of development. Ambiotis thus helps them to put faster on the market more efficient and innovative compounds on immuno-inflammatory … Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 2 | 15 |
 | Extem Extem Bioscience has been developing advanced technologies for the use of regenerative medicines and is expanding our offerings. We have identified 3 key areas that will undergo drastic shifts over the next 10 years and are in need of a multidisciplinary evidence based approach. By collaborating and co-developing with leading institutions within North America we see a brighter, healthier and trans formative future. | 0 | 3 |
 | Nexstim We enable personalized and effective therapies and diagnostics for challenging brain diseases and disorders. Nexstim is a Finnish, globally operating medical technology company. Founded in 2000 in Helsinki, Finland, Nexstim is committed to improving the quality of life of patients with significant unmet clinical needs. Our mission is to enable personalized and effective therapies and diagnostics for challenging brain diseases and disorders. Nexstim has developed a world-leading non-invasive brain stimulation technology called SmartFocus®. It is a navigated transcranial magnetic stimulation (nTMS) technology with highly sophisticated 3D navigation providing accurate and personalized targeting of the TMS to the specific area of … Type: SMB Activities: deeptech biotech healthtech | 0 | 52 |
 | Phost'in Therapeutics Unmask Cancer, Elicit Immune Response Phost’in Therapeutics discovers and develops First-In-Class Glycocalyx Modifiers for selective treatment of cancers and other serious diseases. A new and innovative player in the field of Glyco-Immuno-Oncology, Phost’in Therapeutics develops a class of highly potent anti-cancer NCEs (new chemical entities) targeting a key glycosylation mechanism responsible for suppressing the immune response. Our first generation of Glycosylation inhibitors aims to unblock immune response and down-modulate invasiveness for the treatment of aggressive solid tumors. Glyco Immuno Oncology Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 11 | 14 |
 | BIMINI Biotech Curing cancer BIMINI Biotech BV is an innovative biotech start-up that is developing unique compounds for oncology. Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 1 | 6 |
 |  RhyGaze AG Innovating vision RhyGaze AG is pioneering a transformative approach with cone optogenetics, which has the potential to revolutionize vision restoration for patients suffering from blindness. pharmaceutical development, optogenetics, gene therapy, ophthalmology, and pharmaceutical research Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 0 | 7 |
 | Reddot Biotech Inc. We focus on the production and sales of high quality ELISA Kits, antibodies, and molecular biology products. We focus on providing customers in the global marketplace with timely customer service, reliable supply, and products with superior quality and performance. We thrive on competition, innovation and fast resource allocation for customer needs. Reddot Biotech Inc. currently focuses on the sales of ELISA kits for pharmaceutical, laboratory, medical and scientific research use. We currently provide more than 6000 different kinds of ELISA kits. We are committed to R&D to bring customers top quality products providing accurate, reliable and fast results. With extensive … Type: Startup Activities: biotech manufacturing deeptech | 0 | 5 |
 | Entourage Health Award-winning cannabis brands & products. Crafted with pride, by people who care. Entourage Health Corp. (previously WeedMD Inc.) is the publicly traded parent company of Entourage Brands Corp. (formerly WeedMD RX Inc.) and CannTx Life Sciences Inc., licence holders and producers of cannabis products for both the medical and adult-use markets. The Company owns and operates a 158-acre state-of-the-art greenhouse, outdoor and processing facility located in Strathroy, Ontario as well as a fully-licensed 26,000 sq. ft. Aylmer, Ontario-based extraction, processing and distribution facility. With the addition of Starseed Medicinal, a medical-centric brand, WeedMD has expanded its multi-channeled distribution strategy. Starseed’s … Type: Startup Activities: biotech deeptech manufacturing Technologies: Synthetic Biology | 1 | 122 |
 | Aspect Biosystems Developing bioprinted tissue therapeutics to transform how we treat some of the most elusive diseases. Aspect Biosystems is a biotechnology company pioneering the development of bioprinted tissue therapeutics to transform how we treat some of the most elusive diseases. Aspect’s bioprinted tissue therapeutics are designed to replace, repair, or supplement biological function inside the body. Aspect is creating these next-generation cell therapies by applying its full-stack tissue therapeutic platform, which integrates proprietary AI-powered bioprinting technology, computational design tools, therapeutic cells, and advanced biomaterials. Aspect is advancing a pipeline of bioprinted tissue therapeutics across multiple disease areas in the endocrine and … Type: Startup Activities: deeptech biotech Technologies: 3D Printing New Materials Synthetic Biology | 12 | 112 |
 | NURO CORP. Manufacturer of the NUOS platform allowing patients to communicate and compute by brain, instantly and without surgery. The Manufacturer of NUOS. NUOS allows any human being to communicate and compute by Brain. Instantly and without any surgery. Visit www.nuro.ca for more information. - 2017 Canada's FedDev Award Recipient. - 2018 Grand Prize Winner of 2 MIT Competitions: The MIT Future of Healthcare Hacking and the MIT Barracuda Bowl (across all Healthcare disciplines). - 2018 Canada's NRC-IRAP Award Recipient. - 2019 Province of Ontario's MaRS Discovery District Award Recipient. - 2019 Waterloo MedTech Top Start-Up Award Recipient. - 2019 Ontario Centres … | 9 | 3 |
 | Imeka We specialize in brain imaging specifically white matter, neuroinflammation, free-water and more. Imaging What Matters. Imeka is currently the only company to combine diffusion imaging and AI to map white matter integrity and get insights on neuroinflammation, demyelination and axonal loss. Therefore, with our non-invasive technology, we minimize risks for our pharma and biotech clients in the development of treatments for neurodegenerative diseases. Imeka’s main goal is to play an influential role in the search and development of cures for brain disease. Imeka’s diffusion imaging tools are able to measure extracellular water fraction (free-water), which is sensitive neuroinflammation. The technology … Type: Startup Activities: healthtech deeptech biotech Technologies: A.I. | 3 | 19 |
 | eNUVIO - Microfabricated Devices for Next-generation Cell Culture Helping you create human-relevant in vitro models! Imagine a world where your experiments are cutting-edge, yet straightforward to perform, analyze and interpret, experiments that are time-saving, more accurate and more physiologically relevant. All this so you can get results sooner and move closer to your goal. This world is our vision! We’re committed to developing next-generation technologies for you. Powered by scientists, we design and produce innovative microfabricated devices with feature-sized components that match the dimensions of biological cells, so that you can take full advantage of emerging cell culture technologies, such as stem cells & 3D culture systems. These … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 1 | 5 |
 | Tilray Brands, Inc. A lifestyle company leading the intersection of cannabis, craft beverage, and hemp industries. Tilray Brands, Inc. (“Tilray”) (Nasdaq: TLRY; TSX: TLRY), is a leading global lifestyle and consumer packaged goods company with operations in Canada, the United States, Europe, Australia, and Latin America that is leading as a transformative force at the nexus of cannabis, beverage, wellness, and entertainment, elevating lives through moments of connection. Tilray’s mission is to be a leading premium lifestyle company with a house of brands and innovative products that inspire joy, wellness and create memorable experiences. Tilray’s unprecedented platform supports over 40 brands in over … Type: Startup Activities: deeptech biotech Technologies: SaaS | 3 | 986 |
 | MORSE Consulting Inc. Deciphering pharmaceutical market access signals to create reimbursement success. Established in January 2017, Mani & O’Quinn Reimbursement Strategy Experts (MORSE) Consulting Inc’s vision is to be a leader in strategic pharmaceutical reimbursement consulting with a reputation for honesty, integrity, and collaboration. With a presence in both Toronto and Ottawa, MORSE seeks to effectively understand our client’s challenges and develop viable strategies to navigate the market access landscape. MORSE offers a range of services related to both negotiation and reimbursement strategies. Reimbursement Risk Appraisal, Market Access Appraisal, Advisory Boards, Private Payer PLA Strategy, PLA Seminar, Negotiation "Revitalization", Ongoing Strategic Advice, Reimbursement … | 3 | 15 |
 | Winterlight Labs Monitoring cognitive impairment through speech Like a lighthouse providing early warning in the dark of night, changes in language can signal cognitive decline decades before symptoms of dementia become apparent. Currently, over 47.5 million individuals in the world have dementia, and that number is expected to triple by 2050. At WinterLight Labs, we build technology that can quickly and accurately detect signs of cognitive impairment from a sample of speech. A short 1-5 minute snippet of speech can paint a picture about the speaker's cognitive state, including lexical diversity, syntactic complexity, semantic content, and acoustics. The technology can detect the … Type: Startup Activities: biotech deeptech Technologies: A.I. A.I. - Machine Learning A.I. - Natural Language Processing | 5 | 25 |
 | SPOTMYUV SPOTMYUV is your SPF’s new BFF! 💜 One sticker works all day to show you when to re-apply your sunscreen.☀️ #GetSpotted SPOTMYUV® is the world's first clinically proven UV Detection Sticker that gives you a personalized reminder of when it's time to reapply your sunscreen. As you run, swim, sweat, and play, SPOTMYUV's® patented DermatrueTM skin mimicking technology interacts with sunscreen like your skin, giving you a clear view of your sun protection in real time. Nanotechnology, Sun Care, Cosmetics, Consumer Packaged Goods, beauty, skincare, and SPF Type: Startup Activities: nanotech biotech deeptech cosmetics | 4 | 1 |
 | Sus Clinicals, Inc. Enabling our healthcare client partners to accelerate breakthrough cancer solutions. Sus Clinicals solves major problems in qualifying new cancer drugs, devices, diagnostics and therapies. Using a proprietary model of testing on genetically-modified pigs pioneered at the University of Illinois, Sus Clinicals leverages the inherent advantages of a patent-pending large animal testing methodology combined with novel clinical approaches to reduce false positives, model the interactions of multiple diseases, and accelerate progress toward human trials for the most promising therapies. Type: Startup Activities: pettech deeptech biotech Technologies: Synthetic Biology | 0 | 13 |
 | ImpriMed, Inc. AI-driven Personalized Medicine for Cancer Care ImpriMed, founded in 2017 in Silicon Valley, is a leading precision medicine startup revolutionizing cancer treatment with artificial intelligence. The company’s pioneering drug response prediction technology helps reduce costs, accelerate treatment, enhance efficacy, and improve the quality of life for patients. To date, the company’s technology has been deployed across more than 40 U.S. states, and 17,000+ canine and feline blood cancer tests have been performed as of 2024. ImpriMed is now poised to extend its groundbreaking AI-driven approach to human healthcare, redefining the future of oncology treatment with personalized, effective solutions. For additional … Type: Startup Activities: pettech deeptech biotech Technologies: A.I. | 1 | 41 |
 | ELIAS Animal Health Changing the way cancer is fundamentally treated. ELIAS Animal Health is elevating the hope of veterinarians and pet owners alike by changing the way cancer is fundamentally treated. Our approach is profoundly simple: Every canine patient is unique. Every cancer is unique. To ultimately win against this devastating killer, cancer therapy itself must also be unique. The ELIAS Cancer Immunotherapy (ECI®) works by conditioning the immune system to recognize a patient’s unique cancer, and then delivering an army of activated killer T cells to specifically target and attack those cancer cells. Learn more at eliasanimalhealth.com. Type: Startup Activities: pettech biotech healthtech deeptech Technologies: Synthetic Biology | 0 | 11 |
 | Loyal Loyal is developing the first-ever drugs intended to extend the healthspan and lifespan of dogs. Loyal is a clinical-stage veterinary medicine company developing drugs intended to extend the lifespan and healthspan of dogs. In other words, our mission is to help dogs live longer, healthier lives. We’ve already achieved significant milestones on our path to gaining FDA approval for the first lifespan extension drug for any species. We have three products in our pipeline and expect to bring the first product to market in 2025. Our team includes scientists, veterinarians, engineers, operators, and creatives. Join us in our mission to … Type: Startup Activities: pettech deeptech biotech Technologies: Synthetic Biology | 1 | 117 |
 | TerrAscend A leading North American cannabis operator TerrAscend is a leading TSX-listed cannabis company with interests across the North American cannabis sector, including vertically integrated operations in Pennsylvania, New Jersey, Maryland, Michigan, and California and retail operations in Canada. TerrAscend operates The Apothecarium, Gage, and other dispensary retail locations as well as scaled cultivation, processing, and manufacturing facilities in its core markets. TerrAscend’s cultivation and manufacturing practices yield consistent, high-quality cannabis, providing industry-leading product selection to both the medical and legal adult-use markets. The Company owns or licenses several synergistic businesses and brands including Gage Cannabis, The Apothecarium, Cookies, Lemonnade, Ilera … Type: Startup Activities: healthtech biotech deeptech | 1 | 378 |
 | Telo Genomics Genomics Imaging for Precision Medicine Telo Genomics is a biotech company pioneering the most comprehensive telomere platform in the industry with powerful applications and prognostic solutions. These include liquid biopsies and related technologies in oncology and neurological diseases. Liquid biopsy is a rapidly growing field of significant interest to the medical community for being less invasive and more easily replicated than traditional diagnostic approaches. By combining our team’s considerable expertise in quantitative analysis of 3D telomeres with molecular biology and artificial intelligence to recognize disease-associated genetic instability, Telo Genomics is developing simple and accurate products that improve day-to-day care for … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 0 | 14 |
 | Zimitech, Inc. Zimitech is a biotechnology company working on creating sugars with functional benefits for healthier lives. | 0 | 34 |
 | InSyBio A disruptor to Precision Medicine & Nutrition through effective personalization tests empowered with machine-learning InSyBio is a biotechnology pioneer company (www.insybio.com) in personalized healthcare and nutrition which focuses on developing computational frameworks and tools for the analysis of complex life-science and biological data. The key objective of our analysis lies in discovering predictive integrated biosignatures (biomarkers of various categories) and models with increased prognostic and diagnostic aspects for personalized Healthcare and Nutrition Industries. InSyBio has recently expanded its offering including a complete set of services that allows the personalization of nutrition, nutraceutical, vitamin and probiotic products. These services are built … Type: Startup Activities: deeptech biotech Technologies: Data Analytics A.I. - Machine Learning | 3 | 6 |
 | Wysa Global leader in AI-driven mental health support, NHS (ORCHA) certified, FDA Breakthrough Device Designation. Wysa is an AI-enabled Coach for mental and emotional wellness. Launched in 2016, Wysa provides early intervention via it's AI chatbot, library of evidence-based self-help tools, and messaging-based support from human coaches. Anonymous, empathetic and available 24x7, Wysa covers 11 million lives, and has helped over 6 million people in 95 countries through 500+ million conversations. Wysa is a global leader in digital mental health, rated 93% by ORCHA, the digital health app evaluation agency used by the NHS, with a 100% on clinical assurance; and … Type: Startup Activities: healthtech biotech deeptech Technologies: A.I. A.I. - Natural Language Processing Generative A.I. | 14 | 165 |
 | Apeel Developing science-backed, technology-supported solutions that help improve the produce experience on shelf. Apeel's evolving technology stack is built on an unprecedented understanding of produce quality and shelf life. This has only deepened as the use of data and technology have given partners a powerful way to accurately and efficiently evaluate produce for ripeness, freshness, and other attributes. Apeel is developing science-backed, technology-supported solutions that help improve the produce experience on shelf. Sustainable Technologies, Crops, Food, Agricultural Services, Environment, Organic, and Biotechnology Type: Startup Activities: biotech deeptech greentech cleantech agritech Technologies: Bio sourced materials | 5 | 261 |
 | NanOlogy Advancing Intratumoral Drug Therapy Approach: Clinical interest in intratumoral therapy is increasing because of advancements in interventional oncology and growing recognition of the importance of treating the primary tumor across the disease spectrum. Clinical trials are underway by NanOlogy in multiple therapeutic areas to evaluate local delivery of concentrated, sustained chemotherapies to increase solid tumor response, eliminate toxicities associated with systemic agents, and promote favorable immunomodulation. Technology: The NanOlogy commercial scale GMP production platform precipitates dissolved drug substances with sonication and compressed supercritical carbon dioxide to form stable large surface area microparticles (LSAMs) of pure drug containing no excipients or … Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 1 | 9 |
 | Impel Pharmaceuticals Developing life-changing, innovative therapies for diseases with unmet needs Impel Pharmaceuticals is focused on developing and providing transformative therapies for people suffering from diseases with high unmet needs across various disease areas in addition to the central nervous system (CNS), through the pioneering of an optimized approach to drug delivery. We offer and develop treatments that pair the Company’s proprietary Precision Olfactory Delivery (POD®) technology with well-established therapeutics. Intranasal Drug Delivery, Migraine, Parkinson's Disease, CNS Therapeutics, and Autism Type: Startup Activities: healthtech deeptech biotech Technologies: Synthetic Biology | 1 | 41 |
 | One Codex Fast and easy to use microbiome analysis with the leading microbial reference database One Codex is the leading bioinformatics platform for microbial genomics, supporting taxonomic and functional analysis of metagenomic (WGS), 16S, and other sequencing data. We specialize in creating robust, scalable, and secure bioinformatics solutions for metagenomics and microbial genomics, with a strong focus on ease of use. Founded in 2014, the One Codex platform counts thousands of users across leading academic institutions, biotechnology companies, and public sector organizations. One Codex is built on top of Amazon Web Services and is the only microbial genomics offering providing HIPAA-level security, … Type: Startup Activities: deeptech biotech Technologies: Cybersecurity | 1 | 10 |
 | Viridian Therapeutics, Inc. Framing the future of autoimmune diseases Viridian is a biopharmaceutical company focused on engineering and developing potential best-in-class medicines for patients with serious and rare diseases. Viridian’s expertise in antibody discovery and protein engineering enables the development of differentiated therapeutic candidates for previously validated drug targets in commercially established disease areas. Viridian is advancing multiple candidates in the clinic for the treatment of patients with thyroid eye disease (TED). The company is conducting two global Phase 3 clinical trials (THRIVE and THRIVE-2) to evaluate the safety and efficacy of VRDN-001 in patients with active and chronic TED. Viridian’s goal is … Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 2 | 182 |
 | Elektrofi Formulating the Future of BiologicsTM Elektrofi is a biopharmaceutical formulation technology company that is revolutionizing the delivery of biologic therapies by giving patients the ability to control how they want to receive and benefit from life-changing medicines. Our breakthrough hyper concentration microparticle technology platform, HyperconTM, resolves the limitations associated with intravenously delivered biologic therapies by enabling convenient at-home subcutaneous self-administration. With a focus on monoclonal antibodies, therapeutic proteins, and other large molecule drugs, we create, develop, and commercialize subcutaneous biologic therapies in collaboration with strategic partners. We believe a patient-centered healthcare approach can lead to a healthier world. We are … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 3 | 95 |
 | Hunter International Recruiting Connecting Top Talent With Innovative Corporations Nationwide. Hunter International Recruiting is a premier staffing and recruiting firm specializing in sourcing top talent in engineering, IT, finance, accounting, and scientific roles. We deliver service-based solutions to a wide array of clients, including Fortune 1000 companies, with a strong presence across the U.S. In addition to staffing services, Hunter International offers culture consulting and a variety of client programs through our professional services division. Our commitment to excellence and deep industry expertise ensure we consistently deliver the highest quality candidates and comprehensive workforce solutions. To learn more, visit www.hirecruiting.com Recruiting, Engineer, Staffing, … Type: SMB Activities: hrtech biotech deeptech fintech transporttech Technologies: Data Analytics | 7 | 114 |
 | Akrivis Mission-critical air cooling and cleaning with a low carbon footprint. Akrivis solutions cool equipment and deliver cleanroom conditions in modular buildings and cabins. Specialist units delivering exceptional performance, outstanding reliability, and ultra-low energy usage. Type: Startup Activities: biotech deeptech Technologies: Decarbonization | 3 | 18 |
 | Opu Labs, Inc. OPU is a decentralized platform for the healthcare data economy OPU is a decentralized platform for the healthcare data economy. Opu empowers patients, researchers, manufacturers, and medical professionals around the world with the ability to manage, monitor and monetize private and secure health data. Data providers can securely monetize data while retaining complete privacy and control, where data consumers can access private data effortlessly for use in research, business, science, and technology. skincare, AI, dermatology, beauty, blockchain, healthcare, skincare consultation, skincare analysis, skincare products, skincare research, facial analysis, artificial intelligence, ICO, Ethereum, cryptocurrency, Opu Coin, OPU, skincare advertising, and skincare … Type: Startup Activities: healthtech biotech deeptech fashtech Technologies: Blockchain/Cryptocurrency A.I. | 0 | 18 |
 | Editas Medicine What If You Could Repair Broken Genes? What if you could repair broken genes? That is the question we ask ourselves every day at Editas Medicine. We’re a clinical stage genome editing company focused on translating the power and potential of the CRISPR/Cas9 and CRISPR/Cas12a genome editing systems into a robust pipeline of treatments for people living with serious diseases around the world. Our goal is to discover, develop, manufacture, and commercialize transformative, durable, precision genomic medicines for a broad class of diseases. We are a vibrant company full of hope, possibilities, and a belief that, working together as One … Type: Startup Activities: biotech deeptech manufacturing Technologies: Synthetic Biology | 8 | 317 |
 | Medical Informatics Corp. The most actionable & comprehensive AI-powered data for every patient, everywhere, monitored by people who care. Medical Informatics Corp. (MIC) is setting a new standard of care founded on improved patient monitoring, real-time predictive analytics, and patient-centered healthcare. We empower every member of the medical team to improve patient care, expedite intervention, reduce risk, and help create financially strong hospitals by enabling more informed, data-driven decisions. Our SickbayTM️ clinical surveillance and analytics platform features a vendor-neutral Time Series Data Engine (TSDE)TM️ and is cleared as a Class II medical device for patient monitoring, analytics, and alarm distribution. Using Sickbay, physicians, … Type: Startup Activities: healthtech biotech deeptech Technologies: Data Analytics | 13 | 147 |
 | BPGbio, Inc. #AI #biopharma #therapeutics #mitochondrial #proteinhomeostasis #oncology #neurology #raredisease #drugdiscovery BPGbio is a leading biology-first AI-powered clinical stage biopharma focused on mitochondrial biology and protein homeostasis. The company has a deep pipeline of AI-developed therapeutics spanning oncology, rare disease and neurology, including several in late-stage clinical trials. BPGbio’s novel approach is underpinned by NAi, its proprietary Interrogative Biology Platform, protected by over 400 US and international patents; one of the world’s largest clinically annotated non-governmental biobanks with longitudinal samples; and exclusive access to the most powerful supercomputer in the world. With these tools, BPGbio is redefining how patient biology can be … Type: SMB Activities: biotech deeptech Technologies: A.I. Data Analytics Synthetic Biology | 12 | 70 |
 | Caribou Biosciences Clinical-stage biopharmaceutical company developing transformative therapies to treat devastating human diseases Caribou Biosciences is a leading clinical-stage CRISPR genome-editing biopharmaceutical company dedicated to developing transformative therapies for patients with devastating diseases. Our next-generation genome-editing technology enables superior precision to develop cell therapies that are armored to potentially improve activity against diseases. We believe the future of cell therapy is off-the-shelf, and we are advancing our pipeline of off-the-shelf, or allogeneic, cell therapies from our CAR-T cell therapy platform as readily available treatments for patients with hematologic malignancies and autoimmune diseases. Next-generation CRISPR genome editing, allogeneic CAR-T cell therapies, oncology, and … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 11 | 174 |
 | Sirenas Bringing you a new generation of health products inspired by marine biodiversity Over the last decade and working with experts and local communities, Sirenas has sustainably and ethically built one of the largest and most unique collections of marine organisms and plants from diverse ecosystems and geographies. From the deep sea to coral reefs and estuaries. We’ve run these samples through cutting edge and proprietary chemical extraction and analytics, and tested each one in over 70 in-vitro biological assays relevant to human health. The result is the largest repository of information connecting the unchartered chemistry of marine organisms to applications … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 1 | 23 |
 | BIOLIFE4D Build a Heart. Save a Life. Pioneered by accomplished business leaders, guided by world-class biomedical and life science experts, and financed through equity crowdfunding, BIOLIFE4D is driving a movement to transform the treatment of heart disease, the leading cause of death worldwide. Leveraging advances in life sciences and cardiac tissue engineering to build human hearts suitable for implantation, this biotech company is committed to optimizing the process and technology around viable human organ replacement, and making it a safe, accessible, commercially viable, and cost-effective reality. Type: Startup Activities: biotech deeptech healthtech Technologies: Synthetic Biology | 0 | 7 |
 | Torq Labs Torq Smart Clothing: Multi-Sensor Wearable Technology for Athlete Safety and Performance Improvement | Return - To- Play Torq Labs is leading Return to Play and Sports Performance technology with the launch of Torq Smart Clothing; Lightweight, Wireless, Multi-Sensor fitness clothing for athlete safety and performance improvement. Pre-Hab, not Rehab. Our proprietary hardware and motion AI is assisting in return to play research and development to reduce the incidence of crucial joint systems including the knees, hips, ankles, neck, shoulders, and elbows. Full-body analysis, Multi-Sensor Wearable Technology Featured in Foundations the Documentary : https://foundation-thedoc.com/ Founders: Julian Holtzman - CEO Justin Swenson- … Type: Startup Activities: biotech deeptech Technologies: Data Analytics A.I. Sensors Wireless | 1 | 3 |
 | Kebotix Materials for tomorrow, Today Kebotix is a technology company ushering in the future of new materials discovery. Developing the world’s first self-driving lab for materials discovery powered by AI and robotics, Kebotix is committed to accelerating the exploration, discovery, applications and production of new molecules and materials. Type: Startup Activities: deeptech biotech Technologies: New Materials A.I. Robotics | 4 | 10 |
 | Ligandal Ligandal is developing precision molecular therapeutics and targeted delivery technologies. Ligandal is a genetic medicine company that uses nanotechnology to develop targeted and personalised therapies. As a regenerative medicine biotechnology company, Ligandal develops ultra-rapid therapeutics and vaccines for outbreaks and pandemics, in addition to its work in immuno-oncology and rare genetic diseases. Our current focus is on delivering a peptide-based cure to the COVID-19 pandemic (SARS-CoV-2 coronavirus), as part of a broader mission of enabling personalized medicine on a global scale through the power of nanomedicine and gene therapies. Given that increasingly complex disease states require precise and custom-tailored medicine, … Type: Startup Activities: biotech deeptech healthtech nanotech Technologies: Synthetic Biology | 2 | 12 |
 | Reltio Data Unification & Management: Entity Resolution | Multidomain MDM | 360 Data Products At Reltio, we believe data should fuel business success. Our AI-powered data unification and management offerings — Reltio Entity Resolution, Multidomain Master Data Management (MDM), and 360 Data Products—transform siloed data from disparate sources into unified, trusted, and interoperable data. Powered by the Reltio Connected Data Platform, these offerings unify and deliver interoperable data where and when it's needed, empowering data and analytics leaders with unparalleled business responsiveness. Many leading enterprise brands—across multiple industries around the globe—rely on our award-winning data unification and cloud-native MDM capabilities to … Type: Startup Activities: biotech consulting deeptech fintech healthtech insurtech it services martech regtech uxtech Technologies: Data Analytics A.I. A.I. - Machine Learning SaaS | 24 | 571 |
 | Solugen Decarbonizing the physical world. At Solugen, we believe planet-scale change starts with the chemistry we use every day. We’re revolutionizing how things are made with the world’s first carbon negative molecule factory: the Bioforge. Harnessing the power of evolved enzymes, plant-based feedstocks, and clean, catalytic reactions, we are making the materials we need to sustain life on Earth—faster, cheaper, and without emissions or waste. green chemistry, oil and gas chemicals, iron sulfide control, hydrogen sulfide control, corrosion inhibitor, scale inhibitor, production chemicals, oilfield chemicals, enzymes, green chemicals, biobased chemicals, and decarbonization Type: Startup Activities: biotech deeptech manufacturing Technologies: Decarbonization Hydrogen | 18 | 139 |
 | Nara Logics Synaptic Intelligence for better decisions. Nara Logics uses synaptic intelligence to help companies make better decisions. Our cloud-based platform provides better recommendations — for personalization or decision support — with a brain-inspired approach that connects information for real-time contextual responses. Follow us on Twitter at @naralogics to see what we're up to. personalization, big data, synaptic networks, PaaS, neuroscience, recommendations, artificial intelligence, digital transformation, small data, and ai Type: Startup Activities: consulting biotech deeptech Technologies: A.I. | 7 | 18 |
 | Molecular Plasma Group WE ARE HIRING - Contributing to a better world by building technology for single step, dry surface functionalisation MPG offers a disruptive Key Enabling Technology (KET) that enables the creation of a wide range of advanced surface functionalities. Examples of what can be achieved using our Molecular Plasma Technology include: adhesion promotion, one-step immobilisation of bio-molecules, virucidal coatings, silicone-free release functionalities, tune-able super-hydrophobicity or hydrophilicity, microfluidic channeling and much more. We achieve this by activating a surface and covalently binding the precursor molecules onto the surface using our proprietary Molecular Plasma Process. The outcome is a permanently bonded, custom-designed, nano-metric … Type: Startup Activities: biotech deeptech healthtech Technologies: New Materials | 6 | 32 |
 | NFW Shortlisted for the Earthshot Prize 2024, NFW is a biomaterials company innovating with plants, not plastic.TM NFW is a circularity platform for plastic-free performance materials. NFW follows three Ground Rules in everything we develop: start well, stay clean, end well. While nearly everything in the built world relies on some type of plastic that began as crude oil and that will become plastic pollution, we are establishing a new material reality. We believe all materials should begin and end as nutrients, ready for the next growth cycle—true circularity. Our multi-material platform serves a wide range of industries—from fashion and footwear … Type: Startup Activities: biotech cleantech deeptech greentech Technologies: New Materials Bio sourced materials | 19 | 207 |
 | Mi Terro® Engineer agricultural waste into high-value, low-cost, and scalable biomaterials to end microplastics and hunger. Mi Terro is a venture-backed advanced material company that engineers agricultural waste into high-quality, low-cost, and scalable biomaterials to end microplastics – this is a first-of-its-kind approach. We are excited to see such a significant leap forward in our ability to manipulate nature’s most diverse and abundant building blocks. Our technologies are patented and are USDA Bio-based Certified. Mi Terro uses a selection of biopolymers and natural fibers with the aim of maximizing the use of agricultural side streams (non-food feedstock) and certified biomasses. While bio-based, … Type: Startup Activities: agritech biotech cleantech deeptech greentech Technologies: Bio sourced materials New Materials Synthetic Biology | 12 | 13 |
 | Streamline Genomics Democratizing precision medicine Streamline Genomics is developing a platform to help clinicians and researchers benefit from genomic sequencing without the need for data analysis expertise. Type: Startup Activities: biotech deeptech Technologies: Data Analytics | 4 | 2 |
 | FREDsense Technologies Fastest provider of PFAS sample analysis in the lab and field. FREDsense is the fastest provider of PFAS sample analysis in the lab and field helping developers, operators, and consultants expand screening programs, optimize destruction and remediation efforts, and accelerate PFAS mitigation efforts globally. We apply our decade’s worth of innovative rapid test development for hard-to-detect compounds and parameters and using the power of biology, quickly and affordably help organizations understand exactly what’s in their water. Synthetic Biology, Water Quality Monitoring, Cleantech, Biotechnology, Sensors, Instrumentation, IoT, PFAS, and Analytical Testing Type: Startup Activities: biotech deeptech greentech water management cleantech Technologies: IoT Sensors Synthetic Biology | 2 | 30 |
 | conversationHEALTH As of January 8, 2024, conversationHEALTH has joined forces with Swoop (www.swoop.com), revolutionizing patient and provider engagement throughout the healthcare industry. This strategic partnership combines conversationHEALTH's expertise in developing advanced conversational AI solutions with Swoop's proficiency in creating precise DTC and HCP audiences. Together, we aim to deliver an unparalleled engagement solution that offers real-time, personalized interactions for patients and healthcare providers, allowing pharmaceutical brands to seamlessly connect with customers and meaningfully transform their websites. Stay tuned as we embark on this journey to reimagine healthcare communication, enhancing user experience and driving positive patient outcomes. Please follow along at Swoop … Type: Startup Activities: healthtech consulting it services biotech deeptech Technologies: A.I. - Deep Learning A.I. A.I. - Machine Learning Data Analytics Generative A.I. SaaS A.I. - Natural Language Processing | 12 | 346 |
 | Treventis Corporation TREVENTISTM Corporation is dedicated to treating and preventing protein misfolding diseases. We utilize a proprietary, patent-pending discovery engine – Common Conformational Morphology (CCM) – to identify druggable active sites in misfolded protein targets. CCM combines unique in silico models with deep expertise in model development (in vitro, ex vivo, in vivo) to enable rational drug design against misfolded protein targets. Our lead program focuses on anti-misfolding small molecules in tauopathy (3R, 4R, familial mutations and mixed) with relevance to Alzheimer’s disease. We have further CCM-driven efforts in oncology and other neurodegenerative diseases that show the wide utility of our technology … Type: Startup Activities: healthtech deeptech biotech Technologies: Synthetic Biology | 1 | 18 |
 | ACTO AI-Powered Intelligent Field Excellence for Life Sciences ACTO is an AI-powered Intelligent Field Excellence (IFE) platform built for Life Sciences that helps Sales, Marketing, and Medical teams improve customer engagement and brand performance by turning field professionals into “Masters of the Message” who engage HCPs and their support teams with authority and impact. With ACTO, #Biopharma companies can ensure field professionals are always competent, confident, and credible, delivering the right message to HCPs in face-to-face interactions, while providing senior leaders and frontline managers with the insight they need to drive continuous field force effectiveness. Intelligent Field Excellence, Artificial Intelligence, Sales … Type: Startup Activities: deeptech edtech it services biotech Technologies: SaaS | 12 | 93 |
 | MetaOptima Technology Inc. Intelligent Dermatology | Striving to empower patients & care providers with innovative tools for better care outcomes. MetaOptima: empowering users with advanced technologies MetaOptima is a digital health tech company dedicated to revolutionizing the dermatology and skin care industry with affordable, effective and intelligent tools. In order to provide state-of-the-art care, both medical professionals and their patients should be equipped with advanced tools. We are proud to offer two products designed to enhance the quality of patient care and organization while streamlining services for maximum efficiency: DermEngine and MoleScope. DermEngine is an intelligent skin analytics platform designed to provide medical … Type: Startup Activities: healthtech deeptech biotech Technologies: Data Analytics | 2 | 26 |
 | MediPharm Labs MediPharm Labs was created in 2015 by a handful of industry experts in Ontario. With the medicinal benefits of cannabis firmly established – and with a global patient market demanding quality cannabis oil – MediPharm Labs was born. While initially exploring options to cultivate cannabis plant, MediPharm Labs came to recognize the opportunity for a select focus on cannabis concentrates. MediPharm Labs set out to master this area of production, and rely on the many cultivating experts to provide quality raw materials. In 2016, MediPharm labs submitted an application to Health Canada for approval to distribute medicinal cannabis oil. Proudly, … Type: Startup Activities: biotech deeptech healthtech manufacturing Technologies: Synthetic Biology | 0 | 142 |
 | ElyssaMed SAS ElyssaMed® will develop the first therapeutic treatment for clinical use comprising several antigenic peptides (epitopes) derived from CTPP and selective for non-small-cell lung cancer, combined with an already marketed vaccine adjuvant. This product once administered to lung cancer patients, will amplify the patients' specific immune responses against tumor cells expressing the antigen CTPP and lead to their destruction. Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 4 | 2 |
 | AbTx Antibody for Therapy AbTx is a preclinical stage biotech company developing the next generation of oncology treatments to treat incurable cancers. AbTx platform is developing mAb innovative enzymatic conjugation. Our platform unlock New Frontiers in Medicine to overcome ADC major drawbacks associated targeting solid tumors by generating antibody Fragment Drug Conjugates (FDCs). ADC, Oncology, and drug develoment Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 7 | 3 |
 | PEPR MED-OOC Exploratory research program on organs and organoids on chips The Exploratory Research Program Organs and organoids on chip (Med-Ooc) aims to deploy in France a new generation of biological models thanks to the development of organs and organoids on chip (O & amp; OOC). He is co -piloted by CEA, CNRS and Inserm and funded by France 2030. It has a budget of € 48.4M operated by the ANR. Organs and organoids on chips, they are miniaturized devices containing living cells in a controlled microenvironnement. They are able to reproduce the structure, the operation, and the interactions between organs. These … Type: Research & Education Activities: deeptech biotech Technologies: Synthetic Biology | 10 | 1 |
 | Akron Bio Powering the future of medicine Since 2006, Akron’s mission is to provide GMP-compliant materials and services that enable innovators to develop and commercialize advanced therapies. Along with its line of GMP quality cytokines, growth factors, blood-derived products, and custom media, Akron specializes in manufacturing custom plasmids and endonucleases to support viral vector and gene editing technologies. Akron’s newly opened 110,000 sq. ft. manufacturing facility operates in line with FDA 21 CFR Part 11 and Eudralex Vol 4 Annex 11 standards. Akron provides advanced therapy developers the scale, compliance, flexibility, and regulatory support to develop novel technologies from pre-clinical through to … Type: SMB Activities: deeptech manufacturing biotech Technologies: Synthetic Biology | 1 | 112 |
 | re.flex - Physical therapy made simple Motion tracking sensors that enable your patients to finish their last stage of the physical rehabilitation at home. Motion tracking sensors that enable your patients to finish their last stage of the physical rehabilitation at home, under your team's supervision. medical device, physiotherapy, telerehabilitation, orthopaedic physiotherapy, physical therapy, remote patient monitoring, physiotherapy device, and physiotherapy wearable Type: Startup Activities: healthtech biotech Technologies: Sensors | 1 | 4 |
 | Evelo Biosciences Clinical stage biotech company developing a new modality of oral biologics that act on cells in the small intestine. Evelo Biosciences is a clinical stage biotechnology company developing orally delivered product candidates that are designed to act on the small intestinal axis, SINTAXTM, with systemic therapeutic effects. SINTAX plays a central role in governing the immune, metabolic, and neurological systems. The Company’s first product candidates are pharmaceutical preparations of single strains of microbes selected for their potential to offer defined pharmacological properties. Evelo’s therapies have the potential to be effective, safe, and affordable medicines to improve the lives of people … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 4 | 21 |
 | AniCell Biotech Extending the ACTIVE life of Animals! AniCell is a biotech company that extends the ACTIVE life of animals with products generated non-invasively from the miracle of birth and used to accelerate regeneration of tissue and bone in injured animals. AniCell Video http://youtu.be/2H8qZLmNChY Cellular Biology, Regenerative Products, Stem Cells, Equine, Biotechnology, and Amnion Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 0 | 12 |
 | 9th Dimension Biotech, Inc. Planting the seeds of human health. PLANTING THE SEEDS OF HUMAN HEALTH. First in the world to offer the age-reversing, lifespan and healthspan enhancing Osmotin plant protein product line. Available now in the US and worldwide. Visit www.osmotin.com for more info. biotech, cell life and death cycle, plant biotechnology, human health, age-reversing, and agriculture Type: Startup Activities: biotech deeptech agritech Technologies: Synthetic Biology | 0 | 2 |
 | Maternova, Inc. The leading marketplace for cutting-edge medical innovations in maternal, newborn & reproductive health. Maternova, Inc. is the leading trusted resource for cutting edge medical innovations in women's health and newborn health. Governments, Ministries of Health, NGO's and healthcare professionals around the world partner with Maternova to procure trusted and rigorously tested pathbreaking technologies. We have a network of over 50,000 policymakers, clinicians, midwives, and thought leaders as part of our sphere of influence. To learn more about how your organization can work with Maternova, as either a client or manufacturer looking to commercialize your products, please contact us. Learn more: … Type: Startup Activities: healthtech biotech civictech deeptech Technologies: Synthetic Biology | 6 | 12 |
 | Antidote Technologies Where patients meet research Antidote is on a mission to catalyze medical innovation by successfully connecting patients and researchers as the best-in-class recruiter for clinical studies. Antidote was launched as TrialReach in 2010 and rebranded to Antidote in 2016. We're based in New York, NY and London, U.K. For more information, visit http://www.antidote.me. Clinical Trials, Pharmaceuticals, Medical Research, Clinical Research, Patient Recruitment, Patient Engagement, and Patient Centricity | 7 | 38 |
 | Nimbix Nimbix is the leading #HPC #cloud platform provider. Since July 30, 2021, Nimbix is part of Atos. Nimbix is the leading provider of purpose-built cloud computing for AI, Machine Learning and High-Performance Computing. Powered by JARVICETM, Nimbix’s patented software platform, the Nimbix Cloud provides high-performance software as a service, dramatically speeding up data processing for enterprises in Energy, Life Sciences, Manufacturing, Media and Retail. Nimbix delivers its innovative accelerated high-performance platform services and applications from its world-class data centers. Since July 30, 2021, Nimbix is part of Atos. https://www.linkedin.com/company/atos/ High Performance Cloud Computing, FPGA Accelerators, GPU Computing, Cloud based Supercomputing, … Type: Startup Activities: biotech deeptech Technologies: A.I. - Machine Learning A.I. | 13 | 12 |
 | EpiBone, Inc. EpiBone is a revolutionary bone reconstruction company that allows patients to “grow their own bone”. EpiBone’s pioneering technology utilizes a scan of the patient’s bone defect and the patient’s own stem cells to construct and cultivate a defect-specific autologous-like bone graft. EpiBone is strategically positioned to provide a superior bone graft that will provide exact defect repair, a simplified surgical procedure, improved bone formation and regeneration, and shorter recovery times, without the complications of foreign body implantation, to the over 900,000 patients who undergo bone-related surgeries each year. Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 6 | 25 |
 | LSPedia Leading traceability SaaS company for food, drug, and consumer products with turn-key compliance to DSCSA, FMD, cGMP LSPedia is the leading provider of turnkey FDA (DSCSA) compliance solutions and supply chain software solutions to the pharmaceutical industry. Manufacturers, wholesale distributors, dispensers, GPOs, and health systems use LSPedia’s solutions to make, move, track, verify, receive, and service their serialized products. Built with workflow, automation, and data security at the core, our solutions are transforming compliance, unifying supply chain, and enabling trading partners from different platforms to work together seamlessly. LSPedia’s OneScan, RxChain, and Investigator technologies brings error-free and keyboard-free operations with … Type: Startup Activities: biotech deeptech Technologies: SaaS | 3 | 70 |
 | Enodia Therapeutics Transforming treatment for cancer inflammation viral infection | Unveiling the Translocon to unlock innovative therapies Enodia Therapeutics, a French biotech company, is advancing first-in-class treatment for cancer, inflammatory diseases, and viral infections by targeting the translocon, a key gateway for protein secretion in the cell. Harnessing a cutting-edge AI-driven approach, we are developing selective small molecule inhibitors that block secretion and promote the degradation of pathological proteins at their source. Emerging from the Institut Pasteur and nurtured by Argobio, Enodia is built on breakthrough science with a singular mission: unveiling the translocon to unlock innovative therapies. Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 2 | N/A |
 | acib GmbH Innovations from Nature The Austrian Centre of Industrial Biotechnology (acib) replaces conventional industrial processes by new, more ecological and economical methods that are adopted from nature. Therefor acib can rely on 30+ years of experience and a network of 180+ mostly longterm international scientific and corporate partners and 200+ researchers in the multiple disciplines of industrial biotechnology and bioengineering. The acib network meets the needs of of the biotechnological, chemical and pharmaceutical industry and is the preferred partner for competitive research in industrial biotechnology – focused on biocatalysis, enzymes and (pharmaceutical) protein production. acib partners get access to innovative scientific … Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 1 | 191 |
 | Laboratoire SIMBA EA 7502 Laboratory of synthesis and isolation of bioactive molecules (Faculty of Pharmacy, University of Tours) Development of new methodological tools for the synthesis and functionalization of heterogeneous entities Synthesis and isolation of molecules with anti-infectious and anti-cancer Innovation in extractive chemistry: centrifugal sharing chromatography, deep eutectic solvents Organic chemistry, extraction of natural products, and medicinal chemistry Type: Startup Activities: deeptech biotech Technologies: Bio sourced materials | 0 | 4 |
 | UNVEIL Easily detect your biological nanoparticles A spin-off from the Institut d'Optique Graduate School, Université Paris-Saclay, UNVEIL is a deeptech start-up that aims at facilitating the development and production of biologics (drugs derived from living organisms, such as messenger RNA vaccines, as opposed to chemical ones). These biologics (gene therapy, RNA vaccines, etc.) are transported to the target site in the human body by nanometric vectors (viruses or lipid nanoparticles). R&D and production of these biomedicines is hampered by the lack of effective technology to measure vector loading. UNVEIL has developped an optical, label-free instrument capable of quickly and easily measuring … Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 11 | 3 |
 | GenoTher The Biocluster that is shaping the future of Gene Therapy With 68 DNA or RNA gene therapies approved, of which 48 in just the past five years, gene therapy has emerged as a transformative frontier in medicine. Harnessing this potential, the French government has taken a decisive step forward by funding the creation of GenoTher, the first European biocluster exclusively dedicated to gene therapy, under the ambitious France 2030 initiative. 🌍 Located in Paris and Evry, GenoTher is set to become a global hub for innovation, bringing together leading researchers, clinicians, industry leaders, and policymakers to accelerate the development of … Type: NGO, Think-tanks, Ed, & Culture Activities: deeptech biotech | 3 | 1 |
 | AEterna Zentaris Inc. Aeterna Zentaris is focused on serving the unmet medical needs of patients with rare endocrine diseases Aeterna Zentaris Inc. is a specialty biopharmaceutical company commercializing and developing therapeutics and diagnostic tests. The Company’s lead product, MacrilenTM (macimorelin), is the first and only U.S. FDA and European Commission approved oral test indicated for the diagnosis of adult growth hormone deficiency (AGHD). MacrilenTM is currently marketed in the United States through a license agreement with Novo Nordisk and Aeterna Zentaris receives double-digit royalties on sales. Aeterna Zentaris owns all rights to macimorelin outside of the U.S. and Canada. Aeterna Zentaris is also … Type: SMB Activities: deeptech healthtech biotech Technologies: Synthetic Biology | 1 | 33 |
 | INTHERES INRAE ENVT Therapeutic innovations and resistances Inthere research is articulated around the exploration of doses-exposures-effects of antibiotics and internal and external antiparasitaires. Its purpose is to produce innovative solutions which lead to a reduced and optimized use of anti-infectious. The work carried out within Inthere is part of a "One-Health" approach to the interfaces of the man-animal-environment triptych. Inthere is a multidisciplinary unit, the collective of which brings together skills in the fields of biology (microbiology, entomology, parasitology, cellular and molecular biologies), analytical chemistry, pharmacology and mathematics. Inthere welcomes university hospital staff (Faculty of Pharmacy), in connection with the Toulouse University Hospital. … Type: SMB Activities: deeptech biotech Technologies: Synthetic Biology | 1 | 347 |
 | LabTAU, Inserm U1032 LabTAU is an INSERM research unit. The research at LabTAU aims at using ultrasound for therapy The research laboratory LabTAU is affiliated to INSERM, the University of Lyon and the Center Leon Bérard. The research at LabTAU aims at using ultrasound for therapy. The expertise of scientists at LabTAU covers acoustics, biomedical engineering, clinical and industrial transfer. In that context, the LabTAU is certified ISO9001 since 2008. Long term collaborations with companies resulted in the clinical evaluation and / or commercialisation of ultrasonic devices for treating prostate cancer (with EDAP TMS), glaucoma (with EyeTechCare) or brain diseases (with Carter) for … | 0 | 40 |
 | Bruker Nano Surfaces & Metrology Industry-Leading Surface Analysis, Mechanical Testing and Life Sciences Instrumentation For 60 years, Bruker has enabled scientists to make breakthrough discoveries and develop new applications that improve the quality of human life. Bruker’s high-performance scientific research instruments and high-value analytical solutions enable scientists to explore life and materials at molecular, cellular and microscopic levels. More specifically, Bruker’s Nano Surfaces Division provides the world’s largest selection of AFMs, stylus profilers, 3D optical microscopes, tribometers, indenters and testers, and fluorescence microscopy systems. Our extensive suite of application-focused instrumentation for materials research addresses the full range of metrology techniques, sample sizes, imaging resolutions, and … Type: Startup Activities: deeptech biotech Technologies: New Materials | 1 | 523 |
 | ISTCT CNRS-Université de Caen UMR 6030 The ISTCT unit "Imagery and therapeutic strategies for brain cancers and fabrics", UMR6030 is a mixed research unit of the CNRS and the University of Caen-Normandy (Unicaen) hosted at GIP Cyceron in Caen. ISTCT's research activities aim to better understand the pathophysiology of hypoxic tumors (brain-poumon) and identify new therapeutic strategies targeting the tumor and its microenvironnement but also to protect the surrounding healthy fabric of anti-cancer treatments such as radiotherapy. For example, in addition to molecular and/or cellular strategies targeting hypoxia, ISTCT studies the interest of Hadrons (carbon and protons ions) in combination with other therapies (chemotherapy, targeted therapies, … Type: SMB Activities: deeptech biotech Technologies: Synthetic Biology | 4 | 8 |
 | MicroBrain Biotech Make your Own Neuronal Network At MicroBrain Biotech, our mission is to revolutionize drug development by embracing ethical and cruelty-free practices, putting humanity at the center of our work, and relentlessly pursuing groundbreaking discoveries. We are committed to creating innovative solutions that improve the quality of life for patients and their families, while treating all living beings with compassion and respect. Through collaboration, scientific excellence, and a commitment to sustainability, we aim to leave a lasting positive impact on the world of healthcare and beyond. Type: Startup Activities: deeptech biotech healthtech Technologies: Synthetic Biology | 0 | 4 |
 | Cell Tereo Shielding life from Radiation CellTereo offers patented cryopreservation technology that shields biological samples from harmful radiation during long-term storage. This includes specialized radiation shielding in cryostats and radiation detection services to maintain the integrity and viability of preserved materials. Supported by: SATT Linksium Grenoble Alpes & Station F, Paris. Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology New Materials | 10 | 1 |
 | Cell Therapy Innovation 360° From Basic Research to Patient Delivery ICE 360 ° is an annual academic event on cell therapies and Immune Cell Engagers for all French and European actors and under the co-president of teachers Gilles Salles and Jean-Yves Blay. For more information and to register, go to www.ice360Congress.com Because T-Cell, cell therapy, and immunology Type: NGO, Think-tanks, Ed, & Culture Activities: deeptech biotech | 1 | N/A |
 | MacroGenics, Inc. MacroGenics is a leader in the discovery and development of innovative medicines that utilize our next generation antibody-based technologies. Our team of 300+ dedicated individuals is advancing a pipeline of product candidates to treat patients with cancer. Our products and platforms have attracted multiple partnerships with leading pharmaceutical and biotechnology companies around the globe. The Company considers its employees to be its most valuable asset and we are committed to providing opportunities for individuals to learn and grow as a means to further their professional development. MacroGenics' corporate culture promotes an atmosphere of innovation, open communication and teamwork where employees … Type: SMB Activities: deeptech biotech Technologies: Synthetic Biology | 1 | 386 |
 | French Society for Cancer Immunotherapy Bridging scientists, doctors, patients & governance to build a stronger com The FITC represents oncologists and research scientists involved in understanding tumor immunity and developing cancer immunotherapies in collaboration with French academic societies (SFI, SFC, LySA etc.). Our objective is to bridge national institutions (HAS, CEPS, INCa, etc. ) and governing bodies (Senate, National assembly) in order to improve the implementation of immunotherapies in France and to increase funding of research in cancer immunology. Cancer, Immunothérapie, Recherche , Oncologie, Médecine, relations patients, Essais Cliniques, and Recherche Clinique Type: NGO, Think-tanks, Ed, & Culture Activities: biotech deeptech | 1 | 2 |
 | OPALE Carnot Institute The Organization for Partnerships in Leukemia The OPALE Carnot institute is the reference partner to the healthcare industry for the research and development of innovative solutions aimed at diagnosis, treatment and follow-up of patients in the field of leukemia and related diseases, the deadliest blood cancer and first child cancer. Medicine, Hematology, Leukemia, Partnership, and Research Type: NGO, Think-tanks, Ed, & Culture Activities: biotech deeptech | 14 | 7 |
 | Emglev Therapeutics The next generation of of single domain antibodies Emglev is a biotechnology company established in 2023 as a spin-off of Institut Curie dedicated to the discovery and the development of transformative immunotherapies to address unmet medical needs in oncology. By leveraging its unique proprietary platform, expertise and innovative approach, Emglev unlocks the current barriers of conventional antibody discovery to provide unique targets and sdAbs selected fully in vitro and validated for therapeutic applications in any format against any target. At Emglev Therapeutics, we have assembled an experienced, interdisciplinary team with a unique vision : to unlock the next level of … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 4 | 3 |